15 research outputs found
Recommended from our members
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
We sought to identify the full range of founder mutations in BRCA1 and BRCA2 in the Bahamas and to estimate the proportion of all BRCA1 and BRCA2 mutations that are accounted for by founder mutations. We studied 214 Bahamian women with invasive breast cancer, unselected for age or family history. A founder mutation had previously been identified in 49 patients. We conducted full sequencing of the BRCA1 and BRCA2 genes and multiplex ligation‐dependent probe amplification (MLPA) for 156 patients. A novel founder mutation in BRCA2 (exon 17 818delA) was seen in four different patients and five other unique mutations in BRCA1 and BRCA2, including a large deletion (exons 8–9) in BRCA1. In total, a mutation was seen in 58 of the 214 patients (27%); 92% of carriers carried one of the seven founder mutations. Approximately 27% of unselected cases of breast cancer in the Bahamian population are attributable to a mutation in BRCA1 or BRCA2, a prevalence which far exceeds that of any other country. The majority of women who carry a mutation in the Bahamas, carry one of the seven founder mutations, making it possible to offer genetic testing to all women at risk for breast cancer in the Bahamas
Recommended from our members
Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas
The prevalence of BRCA1 and BRCA2 mutations among unselected breast cancer patients in the Bahamas is 23%. It is beneficial to advise relatives of mutation carriers that they are candidates for genetic testing. Women who test positive are then eligible for preventive interventions, such as oophorectomy. It is not clear how often relatives of women with a mutation in the Bahamas wish to undergo genetic testing for the family mutation. Furthermore, it is not clear how best to communicate this sensitive information to relatives in order to maximize patient compliance. We offered genetic testing to 202 first-degree relatives of 58 mutation carriers. Of 159 women who were contacted by the proband or other family member, only 14 made an appointment for genetic testing (9%). In contrast, among 32 relatives who were contacted directly by the genetic counselor, 27 came for an appointment (84%). This study suggests that for recruitment of relatives in the Bahamas, direct contact by counselor is preferable to using the proband as an intermediary
Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas
Population-based testing for BRCA1/2 mutations detects a high proportion of carriers not identified by cancer family history-based testing. We sought to determine whether population-based testing is an effective approach to genetic testing in the Bahamas, where 23% of women with breast cancer carry one of seven founder mutations in the BRCA1 or BRCA2 gene. We determined the prevalence of founder BRCA mutations in 1847 Bahamian women without a personal history of breast or ovarian cancer, unselected for age or family history. We found that 2.8% (20/705) of unaffected women with a family history of breast/ovarian cancer and 0.09% (1/1089) of unaffected women without a family history carry a BRCA mutation. A total of 38% of unaffected women with a known mutation in the family were found to carry the familial mutation. We previously suggested that all Bahamian women with breast or ovarian cancer be offered genetic testing. These current data suggest that additionally all unaffected Bahamian women with a family history of breast/ovarian cancer should be offered genetic testing for the founder BRCA mutations
Operative complications and fetal morbidity encountered in 300 prophylactic transabdominal cervical cerclage procedures by one obstetric surgeon
Resistance in tax and transparency standards: small states’ heterogenous responses to new regulations
In the wake of the financial crisis of 2007–2009, by means of a major Western state-led initiative in tax cooperation designed to eliminate tax evasion in the world, offshore financial centers were required to exchange information on bank accounts, first on request, then automatically. Even though all major offshore financial centers have agreed to the new tax standards, the emerging literature on global tax politics disagrees on their effectiveness. To make sense of these contrasting findings, I argue that we need to shift our focus to the diverse ways that targeted actors have responded to the new standards. I develop a typology of resistance strategies and show why state actors engage in one or the other strategy despite pressure from great powers. New tax treaty data, as well as archival and interview material in the matched cases of the Bahamas and Barbados demonstrate variance in the relationships between governments and the financial industry, and governments and international organizations, which in turn leads to the pursuit of different resistance strategies. Ultimately, by highlighting the heterogeneity of targeted actors’ responses to global standards, the study has important implications for the literature on institutional emergence and design writ large